Review Article
Impact of Volatile Anesthetics on Oxidative Stress and Inflammation
Table 2
Effects of volatile anesthetics on oxidative stress and inflammation in rodents.
| Disease model | Inducer | Anesthetics | Effects | Reference |
| Cardiac ischemia in rat myocyte | Hypoxia | Isoflurane | Antioxidant effects |
[32] | Hydrogen peroxide | Antiapoptosis effects | Neutrophil | Cardioprotective effects |
| Cerebral ischemia in rats | Cerebral artery occlusion | Sevoflurane, isoflurane | Antioxidant effects |
[33] | Anti-inflammatory effects |
| Diabetic rats | Mutation in the leptin receptor gene | Isoflurane | Antioxidant effects |
[34] | Decreased myocardial contraction |
| MODS in mice | Zymosan | Isoflurane | Anti-inflammatory effects | [18] |
| MODS in mice | Zymosan | Isoflurane | Anti-inflammatory effects | [35] |
| MODS in mice | Zymosan | Isoflurane | Antiapoptosis effects |
[36] | Anti-inflammatory effects |
| Inflammation in rats | LPS | Sevoflurane | Anti-inflammatory effects | [37] |
| Inflammation in rats | LPS | Isoflurane | Anti-inflammatory effects | [38] |
| Sepsis in mice | Cecal ligation and puncture | Sevoflurane | Anti-inflammatory effects | [39] |
| Sepsis in rat | Cecal ligation and puncture | Sevoflurane, isoflurane | Anti-inflammatory effects | [40] |
| Rat liver transplantation | ā | Sevoflurane | Antioxidant effects | [41] |
|
|
MODS, multiple organ dysfunction syndrome; LPS, lipopolysaccharide.
|